SREBF2 and neoplasm: Zheng et al. determined that Maprotiline can directly bind and inhibit CRABP1, resulting in dampened ERK-mediated SREBP2 activity and ultimately reducing tumor growth in a hepatocarcinoma xenograft model [117].